Florida Institute for Human and Machine Cognition

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Florida Institute for Human and Machine Cognition sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 3 currently recruiting 3 completed early-phase tilt upper quartile by trial count

Florida Institute for Human and Machine Cognition: 7 sponsored US clinical trials, 3 recruiting.

Florida Institute for Human and Machine Cognition sponsors 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Diabetic Peripheral Neuropathy, with 2 trials.

Upper-quartile sponsor footprint

Florida Institute for Human and Machine Cognition sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

7 total, page 1 of 1

RECRUITING NA

Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy

NCT06591780
RECRUITING NA

Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX)

NCT06507189
RECRUITING NA

Walking Function in Diabetic Peripheral Neuropathy

NCT05965336
NOT YET RECRUITING NA

Adjuvant Nitrate to Boost Exercise-induced Health Benefits in Older Adults

NCT07572266
COMPLETED NA

Ketone Esters for Optimization of Operator Performance in Hypoxia

NCT07065864
COMPLETED Phase 2

Oxytocin on Cold Water Task Performance and Recovery

NCT04738838
COMPLETED Phase 2

Oxytocin for Oxidative Stress and Inflammation

NCT04732247

Phase Distribution

PhaseTrial count
Phase 2 2

Therapeutic Areas

Diabetic Peripheral Neuropathy 2
Cold Exposure 1
Sarcopenia 1
Oxidative Stress 1
Diabetes Mellitus 1
Hypoxia 1
Inflammation 1

What is open in the Florida Institute for Human and Machine Cognition pipeline

3 recruiting of 7 indexed (43% open); 3 completed (43%).

Phase mix: 0 late (III/IV) vs 2 early (I/II) (early-phase heavy).

Top condition: Diabetic Peripheral Neuropathy (2 trials), 6 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Florida Institute for Human and Machine Cognition: open-pipeline peers nationwide

Peers matched on 7 registered trials and 43% open enrollment, not the therapeutic-area sidebar.

Florida Institute for Human and Machine Cognition sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 6.97.07.077.07.07.1 0%10%20%30%40%50% Total trials Recruiting share Florida Institute for Human and Machine Cognition3M4Life Research89bioAbbott Diagnostics DivisionAlphatec SpineClarity PharmaceuticalsColorado Center for Reproductive MedicineDavid Moss
Florida Institute for Human and Machine Cognition sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Florida Institute for Human and Machine Cognition sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 43% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Florida Institute for Human and Machine Cognition page

7 registered trials is a research-attention snapshot, not an endorsement of Florida Institute for Human and Machine Cognition or any single study.

  • 3 of Florida Institute for Human and Machine Cognition's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Diabetic Peripheral Neuropathy is the condition Florida Institute for Human and Machine Cognition studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Diabetic Peripheral Neuropathy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Florida Institute for Human and Machine Cognition pipeline card: 7 registered trials from official public datasets.Report a data error.